PMDA drug package insert

イロクテイト静注用250

PMDA Prescription drug · サノフィ株式会社 · package insert Sep 29, 2025

Key facts

Brand names イロクテイト静注用250, イロクテイト静注用500, イロクテイト静注用750, イロクテイト静注用1000, イロクテイト静注用1500, イロクテイト静注用2000, イロクテイト静注用3000, イロクテイト静注用4000
Nonproprietary names エフラロクトコグ アルファ(遺伝子組換え)
Companies 製造販売元/サノフィ株式会社
Product type Prescription drug
Therapeutic category 遺伝子組換え血液凝固第VIII因子Fc領域 融合タンパク質製剤
Therapeutic category codes 876349
YJ codes 6343442D1022, 6343442D2029, 6343442D3025, 6343442D4021, 6343442D5028, 6343442D6024, 6343442D7020, 6343442D8027
Approval numbers 22600AMX01398000, 22600AMX01399000, 22600AMX01400000, 22600AMX01401000, 22600AMX01402000, 22600AMX01403000, 22600AMX01404000, 23000AMX00841000
Package insert edition 第4版
Package insert date Sep 29, 2025
PMDA document key 780069_6343442D1022_3
PMDA company code 780069

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • Yes PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)